[Spherical remodeling of left atrium in hypertrophic nonobstructive cardiomyopathy]

Kardiologiia
|July 31, 2012
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) often causes spherical remodeling of the left atrium (LA), impairing its contractility. This study identified this common finding in 60% of HCM patients, including nonobstructive forms.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Pathophysiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease.
  • Left atrial (LA) remodeling is a known complication in cardiovascular diseases.
  • Understanding LA mechanics in HCM is crucial for risk stratification.

Purpose of the Study:

  • To investigate the characteristics of left atrial (LA) remodeling in patients with hypertrophic cardiomyopathy (HCM).
  • To assess the impact of LA remodeling on LA contractility in HCM.
  • To propose a novel metric, the remodeling coefficient, for quantifying LA shape changes.

Main Methods:

  • Echocardiography was performed on 69 patients with nonobstructive HCM.
  • Systolic and diastolic longitudinal and transversal dimensions of the LA were measured.
  • LA contractility parameters were calculated, and a remodeling coefficient (transversal/longitudinal dimensions) was derived.

Main Results:

  • Spherical remodeling of the LA was observed in 60% of all examined HCM patients.
  • This remodeling was associated with reduced LA contractility.
  • The remodeling coefficient effectively quantified the degree of LA spherical deformation.

Conclusions:

  • Spherical LA remodeling and reduced contractility are prevalent in HCM, even in nonobstructive forms.
  • The proposed remodeling coefficient may serve as a useful quantitative marker for LA dysfunction in HCM.
  • Further research is warranted to explore the prognostic implications of LA remodeling in HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...